Posts by Admin BioAlps
Calypso enters into agreement to be acquired by Novartis
Calypso’s shareholders will receive an upfront payment of $250 Million upon closing and are eligible to receive up to $175 Million based on the achievement of certain predetermined milestones. Calypso is a leader in the development of Interleukin15 (IL-15) targeted therapies. Calypso, a spin-out from Merck based in Plan-Les-Ouates (Geneva), is focused on…
Read MoreTimeline raises CHF56 Million and partners with L’Oréal
Already backed by Nestlé, the Swiss Health Valley startup co-founded by former EPFL President Patrick Aebischer, now counts a second leading multinational among its investors: L’Oréal. The fact that L’Oréal is investing in Timeline, a pioneering longevity brand, demonstrates the cosmetics giant’s interest in this fast-growing trend,” says Chris Rinsch, co-founder of the…
Read MoreDebiotech launches its engineering house
New year, new challenges! Debiotech, a leader in medical technologies based in Lausanne – Switzerland, announces the launch of its Engineering’s House as part of the strategic pivot initiated at the end of 2021. The aim is to continue supporting medical innovation by making its engineering expertise and proven regulatory methodology available to its customers…
Read MoreTune Insight leads a €1.8 Million project for data collaboration in paediatric emergency units
The EPFL spin-off has created a technology able to move past privacy and security issues for data sharing. The project, funded by the Eurostars programme, will involve paediatric units in hospitals in Italy and Switzerland. Along with Italian and Swiss hospitals from the paediatric emergency research network (PERN), including Insel GruppeSpital in Bern,…
Read MoreStalicla Secures $17.4 Million in Series B Financing
The Geneva-based clinical-stage biopharmaceutical company is advancing precision medicine pipelines for neuropsychiatric and neurological disorders STALICLA announces the successful completion of the first closing of its Series B financing round, securing $17.4 million. Led by SPRIM Global Investments Pte, Ltd, with key participation from core investors, this funding includes a $3.8 million credit…
Read MoreSocorex wins the CSEM Digital Health Journey Award
This SME based in Ecublens (VD), is a world leader in development and manufacture of high-end precision dosing instruments for liquid handling in laboratories and animal health injections. The award, valued at CHF 100,000, will help the company develop a new solution with a strong environmental impact. The company specializes in the development…
Read MoreCHF 400 Million for Digisanté, a programme to transform the Swiss Healthcare system
The Swiss Federal Council wants to start Digisanté, a programme for the digital transformation of the healthcare system. The aim is to facilitate the exchange of patient data, and to improve efficiency, treatment quality and patient safety. The Swiss healthcare system is good, but it is lagging behind when it comes to digitisation.…
Read MoreBioAlps Awards 2023
Dr. Hervé Bourlard receive the BioAlps Academia Award, and Dr. Igor Fish and Dr Nicolas Mermod receive the BioAlps Industry Award.
Read MoreAn implant to restore walking in Parkinson’s patients
Neuroscientists and neurosurgeons from EPFL/CHUV/UNIL, Inserm and the University of Bordeaux have designed a neuroprosthesis to correct the gait disorders associated with Parkinson’s disease. In a study published in Nature Medicine, the scientists detail the development process of the neuroprosthesis which enabled them to treat a first patient suffering from Parkinson’s disease, enabling him to…
Read MoreCancer Research: CHF 1.1 Million for Novochizol SA
Cancer: EPFL and Novochizol SA to collaborate on designing more efficient immunotherapies, with the support of Innosuisse, the Swiss Innovation Agency.
Read More